GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Angelalign Technology Inc (HKSE:06699) » Definitions » Cash Conversion Cycle

Angelalign Technology (HKSE:06699) Cash Conversion Cycle : 45.46 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Angelalign Technology Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Angelalign Technology's Days Sales Outstanding for the six months ended in Dec. 2023 was 21.56.
Angelalign Technology's Days Inventory for the six months ended in Dec. 2023 was 63.45.
Angelalign Technology's Days Payable for the six months ended in Dec. 2023 was 39.55.
Therefore, Angelalign Technology's Cash Conversion Cycle (CCC) for the six months ended in Dec. 2023 was 45.46.


Angelalign Technology Cash Conversion Cycle Historical Data

The historical data trend for Angelalign Technology's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Angelalign Technology Cash Conversion Cycle Chart

Angelalign Technology Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Conversion Cycle
Get a 7-Day Free Trial 5.07 -8.20 -11.77 1.08 37.20

Angelalign Technology Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only -25.10 -22.63 6.16 50.06 45.46

Competitive Comparison of Angelalign Technology's Cash Conversion Cycle

For the Medical Instruments & Supplies subindustry, Angelalign Technology's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Angelalign Technology's Cash Conversion Cycle Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Angelalign Technology's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Angelalign Technology's Cash Conversion Cycle falls into.



Angelalign Technology Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Angelalign Technology's Cash Conversion Cycle for the fiscal year that ended in Dec. 2023 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=22.02+69.29-54.11
=37.20

Angelalign Technology's Cash Conversion Cycle for the quarter that ended in Dec. 2023 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=21.56+63.45-39.55
=45.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Angelalign Technology  (HKSE:06699) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Angelalign Technology Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of Angelalign Technology's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


Angelalign Technology (HKSE:06699) Business Description

Traded in Other Exchanges
Address
No. 500 Zhengli Road, 6th Floor - 7th Floor, Building No. 7, KIC Business Center, Yangpu District, Shanghai, CHN
Angelalign Technology Inc is an investment holding company. It is principally engaged in clear aligner treatment solutions including treatment planning services, manufacturing, and marketing of clear aligners. The company provides dental professionals with self-developed digital orthodontics solutions. The company's Angelalign clear aligner system facilitates dental professionals throughout the entire clear aligner treatment process, including digitally-assisted case assessment support and treatment planning services, provide dental professionals with digitally-assisted case assessment support and treatment planning services, and helps dental professionals design, review and modify treatment plans.
Executives
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
Morgan Stanley 2201 Interest of corporation controlled by you
Carecapital Ea, Inc 2201 Interest of corporation controlled by you
Carecapital Management Group Llc 2201 Interest of corporation controlled by you
Carecapital Moonstone Holdings Limited 2201 Interest of corporation controlled by you
Carecapital Dental Holdings Limited 2201 Interest of corporation controlled by you
Feng Dai 2201 Interest of corporation controlled by you
Shore Lead Limited 2201 Interest of corporation controlled by you
Sky Honour Enterprises Limited 2101 Beneficial owner
Li Huamin 2307 Founder of a discretionary trust who can infl
Carecapital Orthotech Limited 2101 Beneficial owner
Chen Kai 2201 Interest of corporation controlled by you
Jovial Day Global Limited 2201 Interest of corporation controlled by you
Vast Luck Global Limited 2101 Beneficial owner
Xing Zheng Quan Qiu Ji Jin Guan Li You Xian Gong Si 2102 Investment manager

Angelalign Technology (HKSE:06699) Headlines

No Headlines